Inside eLife

Latest

  1. eLife Latest: The costs of publishing

    Changes in annual expenses and publishing volume at eLife show it is possible to run a selective journal with a mid-range publication fee.
  2. eLife Ambassadors: Contributions start to bear fruit

    Outputs from the eLife Ambassadors programme are beginning to emerge from projects on a wide range of topics – from reproducibility and peer review to mentoring and leadership.
  3. eLife and COVID-19: Our response to the pandemic

    eLife’s editors, early-career advisors and executive staff are working to support researchers affected by the ongoing coronavirus outbreak.
  4. eLife and COVID-19: Keeping communications open with online research talks

    eLife hosts online seminars to support early-career researchers to present their research online instead of in person.
  5. Webinar Report: Everything you need to know about Research Resource Identifiers

    In this recent webinar, Anita Bandrowski from the Resource Identification Initiative discusses a relatively easy way to improve the reproducibility of your research.
  6. eLife Latest: Taking steps to increase the diversity of our editorial board

    As the Board of Reviewing Editors reaches 500, we reflect on recent recruitment efforts.
  7. Special Issue: Meet the editors for aging, geroscience and longevity

    Learn more about the group of expert editors reviewing articles for this Special Issue.
  8. eLife Latest: We support statement about sharing research on coronavirus

    The joint statement from Wellcome aims to improve transparency, sharing of data and information of importance to the coronavirus epidemic.
  9. eLife Latest: We name Damian Pattinson as new Executive Director

    Pattinson will lead eLife’s efforts to improve the communication of new research findings across the life and biomedical sciences.
  10. Open Access: eLife supports proposed White House policy

    In an open letter led by PLOS, eLife joins other publishers and societies in support of the proposed White House policy regarding federally funded research.